Research Article

You have full text access to this OnlineOpen article

C1D is a major autoantibody target in patients with the polymyositis–scleroderma overlap syndrome

  1. Geurt Schilders,
  2. Wilma Vree Egberts,
  3. Reinout Raijmakers,
  4. Ger J. M. Pruijn*

Article first published online: 28 JUN 2007

DOI: 10.1002/art.22710

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 56, Issue 7, pages 2449–2454, July 2007

Additional Information

How to Cite

Schilders, G., Egberts, W. V., Raijmakers, R. and Pruijn, G. J. M. (2007), C1D is a major autoantibody target in patients with the polymyositis–scleroderma overlap syndrome. Arthritis & Rheumatism, 56: 2449–2454. doi: 10.1002/art.22710

Author Information

  1. Nijmegen Center for Molecular Life Sciences, Institute for Molecules and Materials, Radboud University Nijmegen, Nijmegen, The Netherlands

*Department of Biomolecular Chemistry 271, Radboud University Nijmegen, PO Box 9101, NL-6500 HB Nijmegen, The Netherlands

Publication History

  1. Issue published online: 28 JUN 2007
  2. Article first published online: 28 JUN 2007
  3. Manuscript Accepted: 7 MAR 2007
  4. Manuscript Received: 8 JAN 2007

Funded by

  • Council for Chemical Sciences of the Netherlands Organization for Scientific Research

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (138K)

REFERENCES

  • 1
    Briani C, Doria A, Sarzi-Puttini P, Dalakas MC. Update on idiopathic inflammatory myopathies [review]. Autoimmunity 2006; 39: 161–70.
  • 2
    Schilders G, van Dijk E, Raijmakers R, Pruijn GJ. Cell and molecular biology of the exosome: how to make or break an RNA [review]. Int Rev Cytol 2006; 251: 159–208.
  • 3
    Alderuccio F, Chan EK, Tan EM. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex. J Exp Med 1991; 173: 941–52.
  • 4
    Bluthner M, Bautz FA. Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein. J Exp Med 1992; 176: 973–80.
  • 5
    Bluthner M, Mahler M, Muller DB, Dunzl H, Bautz FA. Identification of an α-helical epitope region on the PM/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25β autoantigen using immobilized overlapping synthetic peptides. J Mol Med 2000; 78: 47–54.
  • 6
    Mahler M, Raijmakers R, Dahnrich C, Bluthner M, Fritzler MJ. Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen. Arthritis Res Ther 2005; 7: R704–13.
  • 7
    Raijmakers R, Renz M, Wiemann C, Egberts WV, Seelig HP, van Venrooij WJ, et al. PM–Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome. Arthritis Rheum 2004; 50: 565–9.
    Direct Link:
  • 8
    Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, Pruijn GJ, et al. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 2001; 107: 451–64.
  • 9
    Brouwer R, Egberts WV, Hengstman GJ, Raijmakers R, van Engelen BG, Seelig HP, et al. Autoantibodies directed to novel components of the PM/Scl complex, the human exosome. Arthritis Res 2002; 4: 134–8.
  • 10
    De la Cruz J, Kressler D, Tollervey D, Linder P. Dob1p (Mtr4p) is a putative ATP-dependent RNA helicase required for the 3′ end formation of 5.8S rRNA in Saccharomyces cerevisiae. EMBO J 1998; 17: 1128–40.
  • 11
    Mitchell P, Petfalski E, Houalla R, Podtelejnikov A, Mann M, Tollervey D. Rrp47p is an exosome-associated protein required for the 3′ processing of stable RNAs. Mol Cell Biol 2003; 23: 6982–92.
  • 12
    Schilders G, Raijmakers R, Raats JM, Pruijn GJ. MPP6 is an exosome-associated RNA-binding protein involved in 5.8S rRNA maturation. Nucl Acids Res 2005; 33: 6795–804.
  • 13
    Zhu B, Mandal SS, Pham AD, Zheng Y, Erdjument-Bromage H, Batra SK, et al. The human PAF complex coordinates transcription with events downstream of RNA synthesis. Genes Dev 2005; 19: 1668–73.
  • 14
    Cronin ME, Miller FW, Plotz PH. In: SchumacherHR, editor. Primer on the rheumatic diseases. Atlanta: Arthritis Foundation; 1988. p. 20–3.
  • 15
    Frey A, Di Canzio J, Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 1998; 221: 35–41.
  • 16
    Schilders G, Raijmakers R, Malmegrim KC, Vande Walle L, Saelens X, Vree Egberts, et al. Caspase-mediated cleavage of the exosome subunit PM/Scl-75 during apoptosis. Arthritis Res Ther 2007; 9: R12.
  • 17
    Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999; 190: 815–26.
View Full Article (HTML) Get PDF (138K)